Ticker archive · $LENZ

$LENZ Filing Signals & Market Reactions

Delayed, SEO-crawlable recaps of AI-scored catalysts for $LENZ — including observed post-filing price moves. Live streaming stays exclusive to VIP.

? All delayed signals

$LENZ

$LENZ – LENZ Therapeutics Reports Widened Q3 Net Loss to $31.0M, Restructuring and CEO Change

LENZ Therapeutics, Inc.

2026-10-28 00:00:00 UTC · SEC_8K · All $LENZ

?? Negative AI Sentiment (-4.0 / 10)

Q3 net loss widened to $31.0M ($0.99/share) from $16.7M ($0.59/share) YoY.
VIZZ product sales up 50% QoQ, but significant cost pressures persist.
Strategic reorganization launched targeting >50% cut in projected 2027 OpEx alongside CEO succession.

Unlock Live VIP Terminal & Telegram – €10/mo Original filing ?